Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Amneal Pharmaceuticals, Inc.
| Metric | Amneal Pharmaceuticals, Inc. AMRXHealthcare |
|---|---|
| Quality Score | 73 / 100 |
| Revenue (latest) | $3.02B |
| Net income (latest) | $72M |
| Operating margin | 13.1% |
| Net margin | 2.4% |
| Return on equity | −101.8% |
| Return on assets | 2.0% |
| Return on capital (ROCE) | 14.1% |
| Debt / equity | — |
| Revenue growth (YoY) | 8.0% |
| Altman Z″ (distress) | — |
| Accruals / assets | −7.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.